Fumiaki Takahashi

14PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 17, 2026
Prognosis and risk factors by histologic type of malignant ovarian germ cell tumors in Japan: a JSOG gynecologic tumor registry-based study.

|May 29, 2026
Treatment patterns and prognosis of vulvar cancer: a nationwide retrospective analysis from the JSOG tumor registry (2016-2020).

|Nov 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa

|Nov 01, 2024
Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry.

Kensuke Sakai, Wataru Yamagami, Fumiaki Takahashi

|Jul 11, 2024
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study.

Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi

|Aug 15, 2023
Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.

Kosaku Mimura, Takashi Ogata, Yuya Yoshimoto

Pageof 3

Frequent Collaborators

9 joint publications

Wataru Yamagami

8 joint publications

Satoru Nagase

5 joint publications

Yoshihito Yokoyama

5 joint publications

Hideki Tokunaga